VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Revenue

In the year 2025, VYNE Therapeutics had annual revenue of $570.00K with 13.77% growth. VYNE Therapeutics had revenue of $130.00K in the quarter ending December 31, 2025, with 54.76% growth.

• Revenue (ttm): $570.00K
• Revenue Growth: +13.77%
• P/S Ratio: 35.66
• Revenue / Employee: $57,000
• Employees: 10
• Market Cap: 20.33M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	570.00K	69.00K	13.77%
Dec 31, 2024	501.00K	77.00K	18.16%
Dec 31, 2023	424.00K	-53.00K	-11.11%
Dec 31, 2022	477.00K	-454.00K	-48.76%
Dec 31, 2021	931.00K	-20.06M	-95.57%
Dec 31, 2020	20.99M	20.55M	4,638.83%
Dec 31, 2019	443.00K	-3.15M	-87.68%
Dec 31, 2018	3.60M	-987.00K	-21.54%
Dec 31, 2017	4.58M	3.91M	579.82%
Dec 31, 2016	674.00K	-	-
Dec 31, 2015	-	-	-